JP2004536045A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536045A5
JP2004536045A5 JP2002576969A JP2002576969A JP2004536045A5 JP 2004536045 A5 JP2004536045 A5 JP 2004536045A5 JP 2002576969 A JP2002576969 A JP 2002576969A JP 2002576969 A JP2002576969 A JP 2002576969A JP 2004536045 A5 JP2004536045 A5 JP 2004536045A5
Authority
JP
Japan
Prior art keywords
use according
administration
cyclopamine
medicament
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002576969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536045A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/TR2001/000027 external-priority patent/WO2002078703A1/en
Publication of JP2004536045A publication Critical patent/JP2004536045A/ja
Publication of JP2004536045A5 publication Critical patent/JP2004536045A5/ja
Pending legal-status Critical Current

Links

JP2002576969A 2001-07-02 2001-07-02 基底細胞癌及び他の腫瘍の治療におけるシクロパミンの使用方法 Pending JP2004536045A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2001/000027 WO2002078703A1 (en) 2001-07-02 2001-07-02 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009074496A Division JP2009143963A (ja) 2009-03-25 2009-03-25 腫瘍細胞のアポトーシスを阻害するためにヘッジホッグ／スムーズンド信号を使用する腫瘍を治療するための製薬組成物

Publications (2)

Publication Number Publication Date
JP2004536045A JP2004536045A (ja) 2004-12-02
JP2004536045A5 true JP2004536045A5 (enExample) 2005-10-06

Family

ID=21619326

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002576969A Pending JP2004536045A (ja) 2001-07-02 2001-07-02 基底細胞癌及び他の腫瘍の治療におけるシクロパミンの使用方法
JP2010028010A Expired - Fee Related JP5424923B2 (ja) 2001-07-02 2010-02-10 乾癬及び他の皮膚疾患治療におけるシクロパミンの使用
JP2013193304A Ceased JP2014028834A (ja) 2001-07-02 2013-09-18 乾癬及び他の皮膚疾患治療におけるシクロパミンの使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010028010A Expired - Fee Related JP5424923B2 (ja) 2001-07-02 2010-02-10 乾癬及び他の皮膚疾患治療におけるシクロパミンの使用
JP2013193304A Ceased JP2014028834A (ja) 2001-07-02 2013-09-18 乾癬及び他の皮膚疾患治療におけるシクロパミンの使用

Country Status (14)

Country Link
EP (4) EP2862570A1 (enExample)
JP (3) JP2004536045A (enExample)
KR (1) KR20090125833A (enExample)
CN (2) CN1525859B (enExample)
AT (2) ATE305300T1 (enExample)
AU (1) AU2001272892B8 (enExample)
BR (1) BR0117063A (enExample)
CA (1) CA2452151C (enExample)
DE (2) DE60113733T2 (enExample)
DK (2) DK1401438T3 (enExample)
ES (3) ES2534400T3 (enExample)
PT (1) PT1411938E (enExample)
RU (1) RU2312661C2 (enExample)
WO (2) WO2002078703A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
ES2534400T3 (es) * 2001-07-02 2015-04-22 Sinan Tas Uso de ciclopamina en el tratamiento de carcinoma de células basales y otros tumores
US20170326118A1 (en) 2001-07-02 2017-11-16 Sinan Tas Drug treatment of tumors wherein hedgehog/smoothened signaling is utilized for inhibition of apoptosis of tumor cells
CA2452152A1 (en) 2001-07-02 2002-10-10 Sinan Tas Use of cyclopamine in the treatment of psoriasis
AU2006283040B2 (en) 2005-08-22 2011-08-25 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
PT2500360E (pt) 2005-10-31 2015-10-15 Oncomed Pharm Inc Composições e métodos para diagnóstico e tratamento do cancro
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
MY181496A (en) * 2006-10-31 2020-12-23 Government Of The United States Of America Represented By The Sec Dep Of Health And Human Services Smoothened polypeptides and methods of use
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
EP2106439B1 (en) 2007-01-24 2014-11-12 The Regents of the University of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
NZ579361A (en) * 2007-03-07 2012-04-27 Infinity Discovery Inc Heterocyclic cyclopamine analogs and methods of use thereof
US7964590B2 (en) 2007-03-07 2011-06-21 Infinity Discovery, Inc. Cyclopamine lactam analogs and methods of use thereof
EP3190121B1 (en) 2007-12-27 2019-02-20 Infinity Pharmaceuticals, Inc. Methods for stereoselective reduction of cyclopamine 4-en-3-one derivative
WO2009099625A2 (en) * 2008-02-08 2009-08-13 The Board Of Regents Of The University Of Texas System Cyclopamine tartrate salt and uses thereof
MX2011003183A (es) 2008-09-26 2011-04-21 Oncomed Pharm Inc Agentes que se unen a receptor encrespado y usos de los mismos.
US20110275576A1 (en) * 2009-01-06 2011-11-10 Utah State University Carbohydrate-Cyclopamine Conjugates as Anticancer Agents
JP2009143963A (ja) * 2009-03-25 2009-07-02 Sinan Tas 腫瘍細胞のアポトーシスを阻害するためにヘッジホッグ／スムーズンド信号を使用する腫瘍を治療するための製薬組成物
WO2011017551A1 (en) 2009-08-05 2011-02-10 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Ｗｎｔ拮抗劑及治療和篩選方法
KR20130043102A (ko) 2010-04-01 2013-04-29 온코메드 파마슈티칼스, 인크. 프리즐드-결합 작용제 및 그의 용도
WO2012037217A1 (en) 2010-09-14 2012-03-22 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
HK1212216A1 (en) 2012-10-23 2016-06-10 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
HK1211887A1 (en) 2013-02-04 2016-06-03 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
CN104740633A (zh) * 2013-12-26 2015-07-01 中国科学院上海生命科学研究院 Shh信号通路特异性抑制剂的应用
BR112017026103B1 (pt) 2015-06-04 2023-10-03 Sol-Gel Technologies Ltd Composições tópicas com composto inibidor de hedgehog, sistema de entrega tópica e seus usos
WO2017139497A1 (en) * 2016-02-11 2017-08-17 PellePharm, Inc. Hedgehog inhibitor for use in relief of and treatment of pruritus or itching
CA3227688A1 (en) 2021-09-13 2023-03-02 Sinan Tas Effective interventions with aging and diseases of aging of human and their consequences
CN114292279B (zh) * 2022-01-07 2023-05-09 吉林省农业科学院 一种藜芦抗癌有效成分环杷明提取与分离方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851993A (en) * 1994-06-13 1998-12-22 Biotie Therapies Ltd. Suppression of tumor cell growth by syndecan-1 ectodomain
US7098196B1 (en) * 1999-10-13 2006-08-29 Johns Hopkins University School Of Medicine Regulators of the hedgehog pathway, compositions and uses related thereto
WO1999052534A1 (en) * 1998-04-09 1999-10-21 Johns Hopkins University School Of Medicine Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
ATE466850T1 (de) * 1998-09-23 2010-05-15 Res Dev Foundation Tocopherole, tocotrienole, sonstige chroman- und seitenkettenderivate, sowie deren verwendungen
US6291516B1 (en) * 1999-01-13 2001-09-18 Curis, Inc. Regulators of the hedgehog pathway, compositions and uses related thereto
AU780358B2 (en) * 1999-06-08 2005-03-17 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
EP1646395B8 (en) * 1999-11-30 2014-12-17 Curis, Inc. Methods and compositions for regulating lymphocyte activity
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
CA2452152A1 (en) * 2001-07-02 2002-10-10 Sinan Tas Use of cyclopamine in the treatment of psoriasis
ES2534400T3 (es) * 2001-07-02 2015-04-22 Sinan Tas Uso de ciclopamina en el tratamiento de carcinoma de células basales y otros tumores

Similar Documents

Publication Publication Date Title
JP2004536045A5 (enExample)
Nazary Abrbekoh et al. Application of microneedle patches for drug delivery; doorstep to novel therapies
CA2452151A1 (en) Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis
EP1251887B1 (en) Anti-inflammatory pad
ES2272344T3 (es) Preparacion laminar multicapas a base de polimeros hidrofilos para la liberacion rapida de principios activos.
EP2915557B1 (en) Retinoic acid microneedle
EP1602371A3 (en) Valproic acid and derivatives for the sensitisation of human cancer cells to increase efficacy in a combination therapy
WO2021147598A1 (zh) 含氟化合物修饰的阳离子聚合物作为药物载体的应用及制备方法
JP2008526762A5 (enExample)
WO2005084710A3 (en) Nanocell drug delivery system
Wu et al. Localized, on-demand, sustained drug delivery from biopolymer-based materials
CN103933603B (zh) 一种壳聚糖促人表皮生长生物医用胶及其制备方法
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
Chaudhari et al. Mucoadhesive buccal drug delivery system: A Review.
Chu et al. Advances of Smart Stimulus‐Responsive Microneedles in Cancer Treatment
CN115737530A (zh) 基于光动力灭菌且兼具抗氧化作用的微针及其制备和应用
Han et al. Research progress of physical transdermal enhancement techniques in tumor therapy
Qothrunnadaa et al. Patches for acne treatment: an update on the formulation and stability test
CN107019843B (zh) 负压透皮给药装置
ES2251623T3 (es) Dispositivo de cuidado de heridas.
WO2008049903A3 (en) Wide-area parasystemic treatment of skin related conditions
CO5190666A1 (es) Procedimiento para la preparacion de aglomerados esfericos de telitromicina
EP3137052B1 (en) Treatment or prevention of seborrheic keratosis using artemisinin and derivatives thereof
US20140363509A1 (en) Compositions for the treatment of mucous membrane diseases
RU2004103072A (ru) Применение циклопамина для лечения базально-клеточной эпителиомы (карциномы) и других опухолей